Eagle Health Investments »

Moonlake Immunot shares owned by Eagle Health Investments

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Eagle Health Investments from 13F filings

Historical chart of Eagle Health Investments investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Eagle Health Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Eagle Health Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.5M 188k 13.18

More positions owned by Eagle Health Investments

Argenx Se Sponsored Adr (ARGX)
Icon SHS (ICLR)
Natera (NTRA)
Insmed Com Par $.01 (INSM)
Illumina (ILMN)
Guardant Health (GH)
Neurocrine Biosciences (NBIX)
BioMarin Pharmaceutical (BMRN)
Fortrea Hldgs Common Stock (FTRE)
Bridgebio Pharma (BBIO)
Scholar Rock Hldg Corp (SRRK)
EXACT Sciences Corporation (EXAS)
Terns Pharmaceuticals (TERN)
Kymera Therapeutics (KYMR)
Compass Pathways Sponsored Ads (CMPS)

View all positions for Eagle Health Investments

Top funds holding Moonlake Immunot

BVF
Deep Track Capital
Cormorant Asset Management
Logos Global Management
Balyasny Asset Management
Jane Street
Adage Capital Partners GP
Susquehanna International
Vivo Capital
Point72 Asset Management
FMR
Nuveen
Hrt Financial
Citadel Advisors
Leucadia National Corporation

View all funds holding Moonlake Immunot